The effects of green tea polyphenols on drug metabolism

Expert Opinion on Drug Metabolism and Toxicology

Volumn 8, Issue 6, 2012, Pages 677-689

  Yang, Chung S ^a   Pan, Eva ^b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Absorption; Bioavailability; Catechins; Drug metabolism; Efflux; Elimination; Tea polyphenols; Transporters

Indexed keywords

ADENOSYLHOMOCYSTEINASE; BORTEZOMIB; CATECHIN; CLOZAPINE; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 2B; CYTOCHROME P450 3A; DOXORUBICIN; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FLUOROURACIL; GLUTATHIONE TRANSFERASE; GREEN TEA EXTRACT; IRINOTECAN; MG 262; MIDAZOLAM; NICARDIPINE; POLYPHENOL; PROTEASOME INHIBITOR; S ADENOSYLMETHIONINE; SULFOTRANSFERASE; SUNITINIB; TAMOXIFEN; UNCLASSIFIED DRUG; VERAPAMIL;

AREA UNDER THE CURVE; DIET SUPPLEMENTATION; DOWN REGULATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG METABOLISM; DRUG TRANSFORMATION; DRUG TRANSPORT; GLUCURONIDATION; HUMAN; NONHUMAN; PROTEIN EXPRESSION; REVIEW; TEA; UPREGULATION;

ABSORPTION; ANIMALS; BIOLOGICAL AVAILABILITY; BIOTRANSFORMATION; ENZYMES; HERB-DRUG INTERACTIONS; HUMANS; MEMBRANE TRANSPORT MODULATORS; MEMBRANE TRANSPORT PROTEINS; PLANT EXTRACTS; PLANT LEAVES; PLANTS, MEDICINAL; POLYPHENOLS; TEA;

ANIMALIA; CAMELLIA SINENSIS; THEACEAE;

EID: 84862068411     PISSN: 17425255     EISSN: 17447607     Source Type: Journal    
DOI: 10.1517/17425255.2012.681375     Document Type: Review

References (83)

1. Yang CS, Wang X, Lu G, Picinich SC. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 2009;9(6):429-39
2. Yang CS, Lambert JD. Research on tea and health. Pharmacol Res 2011;64(2):85-6
3. Deka A, Vita JA. Tea and cardiovascular disease. Pharmacol Res 2011;64(2):136-45
4. Lambert JD, Sang S, Yang CS. Possible controversy over dietary polyphenols: benefits vs risks. Chem Res Toxicol 2007;20(4):583-5 (Pubitemid 46762092)
5. Schonthal AH. Adverse effects of concentrated green tea extracts. Mol Nutr Food Res 2011;55(6):874-85
6. Sang S, Lambert JD, Ho CT, Yang CS. The chemistry and biotransformation of tea constituents. Pharmacol Res 2011;64(2):87-99
7. Products List. Dietary Supplements Labels Database. Available from: http://dietarysupplements.nlm.nih.gov/dietary/brand.jsp [Cited January 2012]
8. Hou Z, Sang S, You H, et al. Mechanism of action of (-)- epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells. Cancer Res 2005;65(17):8049-56 (Pubitemid 41297287)
9. Lu H, Meng X, Yang CS. Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)- epigallocatechin gallate. Drug Metab Dispos 2003;31(5):572-9 (Pubitemid 36444166)
10. Lu H, Meng X, Li C, et al. Glucuronides of tea catechins: enzymology of biosynthesis and biological activities. Drug Metab Dispos 2003;31(4):452-61 (Pubitemid 36378523)
11. Lu H. Mechanistic studies on the Phase II metabolism and absorption of tea catechins. Toxicology. The State University of New Jersey; Rutgers, New Brunswick: 2002
12. Vaidyanathan JB, Walle T. Glucuronidation and sulfation of the tea flavonoid (-)-epicatechin by the human and rat enzymes. Drug Metab Dispos 2002;30(8):897-903 (Pubitemid 34815419)
13. Sang S, Lee MJ, Yang I, et al. Human urinary metabolite profile of tea polyphenols analyzed by liquid chromatography/electrospray ionization tandem mass spectrometry with data-dependent acquisition. Rapid Commun Mass Spectrom 2008;22(10):1567-78 (Pubitemid 351829698)
14. Sang S, Lambert JD, Hong J, et al. Synthesis and structure identification of thiol conjugates of (-)-epigallocatechin gallate and their urinary levels in mice. Chem Res Toxicol 2005;18(11):1762-9 (Pubitemid 43257759)
15. Leslie EM, Deeley RG, Cole SP. Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology 2001;167(1):3-23 (Pubitemid 32830943)
16. Hong J, Lambert JD, Lee SH, et al. Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)- epigallocatechin-3-gallate and its methyl metabolites. Biochem Biophys Res Commun 2003;310(1):222-7 (Pubitemid 37162786)
17. Hong J, Lu H, Meng X, et al. Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)- epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Cancer Res 2002;62(24):7241-6 (Pubitemid 36025245)
18. Lambert JD, Sang S, Lu AY, Yang CS. Metabolism of dietary polyphenols and possible interactions with drugs. Curr Drug Metab 2007;8(5):499-507 (Pubitemid 47603414)
19. Taipalensuu J, Tornblom H, Lindberg G, et al. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ther 2001;299(1):164-70 (Pubitemid 32905131)
20. Chen L, Lee MJ, Li H, Yang CS. Absorption, distribution, elimination of tea polyphenols in rats. Drug Metab Dispos 1997;25(9):1045-50 (Pubitemid 27396491)
21. Lambert JD, Lee MJ, Lu H, et al. Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice. J Nutr 2003;133(12):4172-7 (Pubitemid 37505494)
22. Yang CS, Chen L, Lee MJ, et al. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev 1998;7(4):351-4 (Pubitemid 28354149)
23. Chow HH, Cai Y, Alberts DS, et al. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev 2001;10(1):53-8 (Pubitemid 32106044)
24. Lee MJ, Maliakal P, Chen L, et al. Pharmacokinetics of tea catechins after ingestion of green tea and (-)- epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev2002;11(10 Pt 1):1025-32 (Pubitemid 35192653)
25. Chow HH, Cai Y, Hakim IA, et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res 2003;9(9):3312-19 (Pubitemid 37082725)
26. Chow HH, Hakim IA, Vining DR, et al. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin Cancer Res 2005;11(12):4627-33 (Pubitemid 40825654)
27. Mulder TP, van Platerink CJ, Wijnand Schuyl PJ, van Amelsvoort JM. Analysis of theaflavins in biological fluids using liquid chromatography- electrospray mass spectrometry. J Chromatogr B Biomed Sci Appl 2001;760:271-9 (Pubitemid 32727250)
28. Choi YH, Chin YW, Kim YG. Herb-drug interactions: focus on metabolic enzymes and transporters. Arch Pharm Res 2011;34(11):1843;63
29. Ge J, Tan BX, Chen Y, et al. Interaction of green tea polyphenol epigallocatechin-3-gallate with sunitinib: potential risk of diminished sunitinib bioavailability. J Mol Med (Berl) 2011;89(6):595-602
30. Golden EB, Lam PY, Kardosh A, et al. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood 2009;113(23):5927-37
31. Kim M, Hong J. Analysis of Chemical Interactions of (-)-Epigallocatechin- 3- gallate, a major green tea polyphenol, with commonly-consumed over-the-counter drugs. Food Sci Biotechnol 2010;19:559-64
32. Chen D, Wang CY, Lambert JD, et al. Inhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites: structure-activity relationship and molecular-modeling studies. Biochem Pharmacol 2005;69(10):1523-31 (Pubitemid 40602453)
33. Muto S, Fujita K, Yamazaki Y, Kamataki T. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat Res 2001;479(1-2):197-206 (Pubitemid 32695501)
34. Netsch MI, Gutmann H, Schmidlin CB, et al. Induction of CYP1A by green tea extract in human intestinal cell lines. Planta Med 2006;72(6):514-20 (Pubitemid 43844678)
35. Wanwimolruk S, Wong K, Wanwimolruk P. Variable inhibitory effect of different brands of commercial herbal supplements on human cytochrome P-450 CYP3A4. Drug Metabol Drug Interact 2009;24(1):17-35
36. Kamenickova A, Vrzal R, Dvorak Z. Effects of ready to drink teas on AhRand PXR-mediated expression of cytochromes P450 CYP1A1 and CYP3A4 in human cancer cell lines and primary human hepatocytes. Food Chem 2011;131:1201-6
37. Yang SP, Raner GM. Cytochrome P450 expression and activities in human tongue cells and their modulation by green tea extract. Toxicol Appl Pharmacol 2005;202(2):140-50 (Pubitemid 40044828)
38. Fong YK, Li CR, Wo SK, et al. In vitro and in situ evaluation of herb-drug interactions during intestinal metabolismand absorption of Baicalein. J Ethnopharmacol 2011
39. Mohamed ME, Frye RF. Inhibitory effects of commonly used herbal extracts on UDP-glucuronosyltransferase 1A4, 1A6, and 1A9 enzyme activities. Drug Metab Dispos 2011;39(9):1522-8
40. Mohamed MF, Tseng T, Frye RF. Inhibitory effects of commonly used herbal extracts on UGT1A1 enzyme activity. Xenobiotica 2010;40(10):663-9
41. Shimada T. Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet 2006;21(4):257-76
42. Pool-Zobel B, Veeriah S, Bohmer FD. Modulation of xenobiotic metabolizing enzymes by anticarcinogens - focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis. Mutat Res 2005;591(1-2):74-92 (Pubitemid 41656060)
43. Chen C, Yu R, Owuor ED, Kong AN. Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch Pharm Res 2000;23(6):605-12
44. Tan XL, Shi M, Tang H, et al. Candidate dietary phytochemicals modulate expression of phase II enzymes GSTP1 and NQO1 in human lung cells. J Nutr 2010;140(8):1404-10
45. Farabegoli F, Papi A, Bartolini G, et al. (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line. Phytomedicine 2010;17(5):356-62
46. Jodoin J, Demeule M, Beliveau R. Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. Biochim Biophys Acta 2002;1542(1-3):149-59
47. Qian F, Wei D, Zhang Q, Yang S. Modulation of P-glycoprotein function and reversal of multidrug resistance by (-)-epigallocatechin gallate in human cancer cells. Biomed Pharmacother2005;59(3):64-9 (Pubitemid 40417515)
48. Zhu A, Wang X, Guo Z. Study of tea polyphenol as a reversal agent for carcinoma cell lines' multidrug resistance (study of TP as a MDR reversal agent). Nucl Med Biol 2001;28(6):735-40 (Pubitemid 32772878)
49. Kitagawa S, Nabekura T, Kamiyama S. Inhibition of P-glycoprotein function by tea catechins in KB-C2 cells. J Pharm Pharmacol 2004;56(8):1001-5 (Pubitemid 39140055)
50. Mei Y, Qian F, Wei D, Liu J. Reversal of cancer multidrug resistance by green tea polyphenols. J Pharm Pharmacol 2004;56(10):1307-14 (Pubitemid 39369002)
51. Netsch MI, Gutmann H, Luescher S, et al. Inhibitory activity of a green tea extract and some of its constituents on multidrug resistance-associated protein 2 functionality. Planta Med 2005;71(2):135-41 (Pubitemid 40363556)
52. Jang EH, Choi JY, Park CS, et al. Effects of green tea extract administration on the pharmacokinetics of clozapine in rats. J Pharm Pharmacol 2005;57(3):311-16 (Pubitemid 40314429)
53. Niwattisaiwong N, Luo XX, Coville PF, Wanwimolruk S. Effects of Chinese, Japanese and Western tea on hepatic P450 enzyme activities in rats. Drug Metabol Drug Interact 2004;20(1-2):43-56 (Pubitemid 38943447)
54. Park D, Jeon JH, Shin S, et al. Green tea extract increases cyclophosphamide-induced teratogenesis by modulating the expression of cytochrome P-450 mRNA. Reprod Toxicol 2009;27(1):79-84
55. Chen X, Sun CK, Han GZ, et al. Protective effect of tea polyphenols against paracetamol-induced hepatotoxicity in mice is significantly correlated with cytochrome P450 suppression. World J Gastroenterol 2009;15(15):1829-35
56. Srinivasan P, Suchalatha S, Babu PV, et al. Chemopreventive and therapeutic modulation of green tea polyphenols on drug metabolizing enzymes in 4-Nitroquinoline 1-oxide induced oral cancer. Chem Biol Interact 2008;172(3):224-34
57. Sahin K, Tuzcu M, Gencoglu H, et al. Epigallocatechin-3-gallate activates Nrf2/ HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Life Sci 2010;87(7-8):240-5
58. Tulayakul P, Dong KS, Li JY, et al. The effect of feeding piglets with the diet containing green tea extracts or coumarin on in vitro metabolism of aflatoxin B1 by their tissues. Toxicon 2007;50(3):339-48 (Pubitemid 47094877)
59. Liu TT, Liang NS, Li Y, et al. Effects of long-term tea polyphenols consumption on hepatic microsomal drug-metabolizing enzymes and liver function in Wistar rats. World J Gastroenterol 2003;9(12):2742-4 (Pubitemid 38054452)
60. Maliakal PP, Coville PF, Wanwimolruk S. Tea consumption modulates hepatic drug metabolizing enzymes in Wistar rats. J Pharm Pharmacol 2001;53(4):569-77 (Pubitemid 32396550)
61. Shen G, Xu C, Hu R, et al. Comparison of (-)-epigallocatechin-3-gallate elicited liver and small intestine gene expression profiles between C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Pharm Res 2005;22(11):1805-20 (Pubitemid 41504334)
62. Catterall F, McArdle NJ, Mitchell L, et al. Hepatic and intestinal cytochrome P450 and conjugase activities in rats treated with black tea theafulvins and theaflavins. Food Chem Toxicol 2003;41(8):1141-7 (Pubitemid 36782519)
63. Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 2000;92(16):1295-302 (Pubitemid 30662093)
64. Barrand MA, Bagrij T, Neo SY. Multidrug resistance-associated protein: a protein distinct from P-glycoproteininvolved in cytotoxic drug expulsion. Gen Pharmacol 1997;28(5):639-45 (Pubitemid 27244411)
65. Kitagawa S, Nabekura T, Takahashi T, et al. Structure-activity relationships of the inhibitory effects of flavonoids on P-glycoprotein-mediated transport in KB-C2 cells. Biol Pharm Bull 2005;28(12):2274-8 (Pubitemid 41757420)
66. Nishikawa M, Ariyoshi N, Kotani A, et al. Effects of continuous ingestion of green tea or grape seed extracts on the pharmacokinetics of midazolam. Drug Metab Pharmacokinet 2004;19(4):280-9
67. Shin SC, Choi JS. Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats. Anticancer Drugs 2009;20(7):584-8
68. Choi JS, Burm JP. Effects of oral epigallocatechin gallate on the pharmacokinetics of nicardipine in rats. Arch Pharm Res 2009;32(12):1721-5
69. Li C, Choi JS. Effects of epigallocatechin gallate on the bioavailability and pharmacokinetics of diltiazem in rats. Pharmazie 2008;63(11):815-18
70. Chung JH, Choi DH, Choi JS. Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats. Biopharm Drug Dispos 2009;30(2):90-3
71. Liang G, Tang A, Lin X, et al. Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer. Int J Oncol 2010;37(1):111-23
72. Lin LC, Wang MN, Tsai TH. Food-drug interaction of (-)- epigallocatechin-3-gallate on the pharmacokinetics of irinotecan and the metabolite SN-38. Chem Biol Interact 2008;174(3):177-82
73. Chow HH, Hakim IA, Vining DR, et al. Effects of repeated green tea catechin administration on human cytochrome P450 activity. Cancer Epidemiol Biomarkers Prev 2006;15(12):2473-6 (Pubitemid 46048307)
74. Donovan JL, Chavin KD, Devane CL, et al. Green tea (Camellia sinensis) extract does not alter cytochrome p450 3A4 or 2D6 activity in healthyvolunteers. Drug Metab Dispos 2004;32(9):906-8 (Pubitemid 39096049)
75. Chow HH, Hakim IA, Vining DR, et al. Modulation of human glutathione s-transferases by polyphenon e intervention. Cancer Epidemiol Biomarkers Prev 2007;16(8):1662-6 (Pubitemid 47294835)
76. Williams SN, Pickwell GV, Quattrochi LC. A combination of tea (Camellia senensis) catechins is requiredfor optimal inhibition of induced CYP1A expression by green tea extract.J Agric Food Chem 2003;51(22):6627-34
77. Engdal S, Nilsen OG. In vitro inhibition of CYP3A4 by herbal remedies frequently used by cancer patients. Phytother Res 2009;23(7):906-12
78. Mirkov S, Komoroski BJ, Ramirez J, et al. Effects of green tea compounds on irinotecan metabolism. Drug Metab Dispos 2007;35(2):228-33 (Pubitemid 46148734)
79. Isozaki T, Tamura H. Epigallocatechin gallate (EGCG) inhibits the sulfation of 1-naphthol in a human colon carcinoma cell line, Caco-2. Biol Pharm Bull 2001;24(9):1076-8 (Pubitemid 32894132)
80. Revesz K, Tutto A, Margittai E, et al. Glucuronide transport across the endoplasmic reticulum membrane is inhibited by epigallocatechin gallate and other green tea polyphenols. Int J Biochem Cell Biol 2007;39(5):922-30 (Pubitemid 46575323)
81. Marnewick JL, Joubert E, Swart P, et al. Modulation of hepatic drug metabolizing enzymes and oxidative status by rooibos (Aspalathus linearis) and Honeybush (Cyclopia intermedia), green and black (Camellia sinensis) teas in rats. J Agric Food Chem 2003;51(27):8113-19
82. Takizawa Y, Kitazato T, Kishimoto H, et al. Effects of antioxidants on drug absorption in in vivo intestinal ischemia/ reperfusion. Eur J Drug Metab Pharmacokinet 2011;35(3-4):89-95
83. Qiao J, Gu C, Shang W, et al. Effect of green tea on pharmacokinetics of 5-fluorouracil in rats and pharmacodynamics in human cell lines in vitro. Food Chem Toxicol 2011;49(6):1410-15